20th International AIDS Conference (AIDS 2014)


HIV and Transgender Issues at AIDS 2014

August 1, 2014

 1  |  2  |  Next > 

Where available -- and information is scarce even from resource-rich countries -- data increasingly report very high rates of HIV in transgender people, especially those who have sex with men. The lack of data is itself a key priority for trans activists, as "without data we remain invisible to services and providers".1

It is therefore appropriate that transgender people are one of the five groups that are the focus of the WHO consolidated HIV guidelines for key populations. The other four are: men who have sex with men, people who inject drugs, people in prisons and other closed settings and sex workers.2

In this article, the term trans* is used to refer to someone who identifies as a sex or gender that is different to the one they were assigned at birth.


At the launch of the WHO guidelines, Kate Montecarlo Cordova from the Association of Transgender People in the Phillipines, talked about the high vulnerability and specific health needs of transgender people. In many countries, the prevalence of HIV among transgender women is as high as or higher, than among men who have sex with men.

For example, in a meta-analysis published in 2013 of 11,066 transgender women from 14 countries -- the US, Asia-Pacific (6), Latin America (5) and Europe (3) -- the pooled HIV prevalence was 19·1% (95% CI 17·4-20·7). This proportion was similar independent of setting: 17.7% in ten low- and middle-income countries and 21·6% in five high-income countries. This data produced an odds ratio for being HIV positive in transgender women (compared with all adults of reproductive age) of 48·8 (95% CI 21·2-76·3).4

Although data and research are still limited, this trend appears to be slowly changing. A global search for "transgender AND HIV" on PubMed presented at the IAS conference in 2012 reported finding 98 results for 2010-2012, compared to only 65 results from 2007-1009 and 18 results from 2002-2006.5

This article briefly reviews the studies presented at the conference and link to interviews with two delegates who are working to ensure even greater presence of trans issues at the meeting in Durban in 2016.

To inform the new guidelines and as a result of its Civil Society Reference Group, WHO worked with trans people on a small qualitative survey (34 people, 14 in-depth interviews). The result stressed that transgender people's needs should be seen as separate from those of other populations (particularly independent of MSM with whom they are usually grouped). Guidelines should include a specific review of evidence and values and preferences, and a specific brief on young transgender people.

The new WHO recommendations are an important first step -- but they are also dependent on supportive legislation (especially to tackle violence), decriminalisation, community empowerment and health services that are available, acceptable and accessible.

Criminalisation and the very real threat of violence were common themes in many of the sessions discussing transgender issues, including a symposium in the main programme on criminalisation, which is also available as a webcast.6 The criminalisation session included legal case examples from the US, India, Nepal and Uganda.

Manisha Dhakal from Nepal focused on examples from the Nepalese legal system, which has a 100-year old code against "unnatural sex" (undefined in terms of specific activity) that is often misapplied and misused against transgender people, especially if they are sex workers. Trans* men are threatened with human trafficking charges if they have relationships with women. Both the police and judiciary lack understanding and transgender people who are the victims of crime are often punished rather than supported. More positively, in 2007 the government granted rights to transgender people including passport recognition for "other" gender status. There is some movement towards a same-sex relationship law and issues surrounding sexual orientation and gender identity policies are addressed in schools and universities.7

The issue of funding to enable adequate and sustainable development of trans* communities -- directly related to the capacity to sustain this critical work -- was the focus of another satellite (co-sponsored by amfAR, the American Jewish World Service (AJWS), and the Global Action for Trans* Equality (GATE).8

Although limited material from the meeting is available -- a missed opportunity that is frustrating for many of these sessions -- the presentation by Joe Wong, Asia Pacific Trans Network (APTN) is available online.9 This talk summarised the findings from an extensive survey of 340 trans* and intersex groups globally, most of which work locally (only 22 work regionally and 6 work globally). Of these groups, 313 were mostly, or exclusively, comprised of HIV positive people.

The resulting 32-page report covers human rights violations against trans* and intersex people, key milestones for organising including the importance of being trans*-led (reported by 198 groups), current and future funding, and recommendations. Although the greatest number of groups came from the US (n=100), 54 organisations were based in Sub-Saharan Africa and 51 were from the Caribbean, Central America and South America. Median annual budgets (91 organisations) were less than US $5,000 (including 66 unfunded groups), and were lower for trans*-led groups. Only seven organisations have a budget higher than $1 million.10

Other notable sessions covering transgender issues in the AIDS 2014 programme include:

  • An oral abstract session (abstracts, slides and webcasts all available) with presentations covering HIV risk in transgender communities, disclosure and persecution, ART support and housing.11 This session included a webcast on the positive effect of progressive Argentinian legislation that supported transgender identity and rights that within one year and directly lead to greater empowerment through schools, education, work and civil society. The webcast is essential viewing and a model for the future.12
  • A peer-led workshop on trans* men who have sex with men -- a group that are rarely considered in HIV-related and LGBT-produced health resources.13
  • A presentation on trans* women and drug use by Nyah Harwood from the Centre for Social Research in Health at the University of New South Wales and the International Network of Women who use Drugs. The lack of scientific data in this talk was directly related to transgender people not historically having an assigned epidemiological category: "The norms of sex and gender that underpin most existing research methodologies constitute trans people as invisible and therefore erase them, characterising the lives of trans women with extraordinary physical and structural violence".14
  • A focus on sex work among transgender women as part of the Lancet special issue on HIV and sex work.15 Despite higher HIV risk, there are almost no interventions focused on this population and changes need to be grounded in empowerment and led by communities. This presentation pointed out the lack of data on the risk related to gender-related surgery.
  • On a policy level, at another satellite meeting on sexual and reproductive health and rights, organised by the International Planned Parenthood Federation (IPPF), Leigh Ann van der Merwe, a transgender woman from South Africa, stressed the importance of including sexual and gender minorities in the post-2015 Millennium Development Goals, as part of a platform that also included young people living with HIV, sex workers, and people who had experienced gender-based violence.16
 1  |  2  |  Next > 

This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.